^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CBT124 (bevacizumab biosimilar)

    i
    Other names: CBT124
    Associations
    News
    Trials
    Company:
    Bio Mabs, Cipla
    Drug class:
    VEGF-A inhibitor
    Related drugs:
    Associations
    News
    Trials